Ascent Solar Technologies, Inc.(Nasdaq: ASTI) was up more than 10 percent from Thursday’s closing price in late-day trading on Friday. The Colorado-based company develops flexible thin-film photovoltaic modules that enable solar power generation.
Most recently, Ascent Solar Technologies announced that it launched a charger for the Samsung Galaxy S III smart phone featuring the company’s ultra light CIGS technology. The new charger will be branded under Ascent’s EnerPlex line of consumer products, and “adds minimal weight and size to the Galaxy S III yet provides significantly improved battery life by harnessing sunlight for electric power,” an August 13 press release stated.
144 million smart phones were sold globally in the first quarter of 2012. Ascent is developing the EnerPlexline utilizing its transformational CIGS technology to bring solar enabled power to a variety of new consumer products such as the widely anticipated next generation iPhone, the August 13 press release stated.
A recent article on Seeking Alpha listed three reasons why Ascent Solar Technologies is “the best solar speculation.” The reasons given by the author include the company’s consumer electronics and iPhone initiatives, the fact that the company has more cash than debt, and finally momentum.
Shares of ASTI are up more than 200 percent over the past three months, according to Yahoo Finance.
MCT-465 and MCT-485 are the first of a family of prospective cancer therapeutics based on the use of our patented TLR3 signaling technology. MCT-465 and MCT 485 are in preclinical development, and are being investigated as prospective treatments for primary liver cancer and triple negative breast cancer.
Cancer stem cells are thought to play a role in a tumor’s resistance to therapy. While significant progress has been made in developing cancer therapies that result in cytoreduction and thus tumor regression, the control of cancer over a longer interval and especially of metastatic disease, remains a key goal. Cancer stem cells are believed to be responsible for cancer relapse by being less sensitive to conventional therapies.
MCET’s representatives will present preclinical research findings for MCT-465 and MCT-485 at CIMT (Association for Cancer Immunotherapy) 2012 in Germany, which is Europe’s largest meeting dedicated to cancer immunotherapy research and development.
About MultiCell Technologies, Inc.
MultiCell Technologies, Inc. (MultiCell) is a biopharmaceutical company. MultiCell is engaged developing therapeutics and discovery tools to address unmet medical needs for the treatment of neurological disorders, hepatic disease, cancer and interventional cardiology and peripheral vessel applications. MultiCell is pursuing research and development targeting degenerative neurological diseases, including multiple sclerosis (MS) and cancer. MultiCell operates three subsidiaries, which include MCT Rhode Island Corp. (wholly owned); Xenogenics Corporation (Xenogenics) (95.3% owned, on an as-if-convertd basis), and MultiCell Immunotherapeutics, Inc. (MCTI), of which MultiCell holds approximately 67% of interests. As of November 30, 2010, the Company’s portfolio of drug candidates, which were in various stages of discovery optimization, and preclinical and clinical development included MCT-125, MCT-465, MCT-475 and MCT-485.
SCOLR Pharma, Inc. (SCLR) announced on Thursday that it has closed the second and final tranche of its previously-announced private placement of its 8 percent Senior Secured Convertible Debentures due 2013 (the “Debentures”). The Company raised a total of $1,190,200 in the offering. The Company intends to use the net proceeds for working capital and other general corporate purposes.
Taglich Brothers, Inc. acted as placement agent in connection with the offering. SCLR will pay Taglich a success fee equal to 7 percent of the gross proceeds of the sale of the Debentures. Taglich Brothers will also receive a warrant to purchase a number of shares of common stock equal to 5% of the total number of shares into which the principal amount of the Debentures sold in the offering are convertible. The exercise price of the warrant is $0.0625 per share.
“The completion of this offering will allow us to continue to focus on the development of our nutritional business and on our efforts to secure licensing or partnership support for our pharmaceutical products,” said SCLR’s President and CEO Stephen Turner in a June 30 press release. “We are making good progress in placing our nutritional products on retail shelves and this capital will enable us to be even more aggressive in those efforts.”
SCOLR Pharma, Inc. is a specialty pharmaceutical company focused on applying its formulation expertise and patented Controlled Delivery Technology (CDT) platforms to develop novel prescription pharmaceutical, over-the-counter (OTC), and nutritional products.
Greenwood Gold Resources Inc. (GGRI) recently announced preliminary plans for preparation of the Summer Property exploration work program, which would fulfill the requirement for undertaking a $350,000 work program on the Summer Property, according to the terms of the Company’s option agreement, according to a June 30 press release.
The proposed work program will include geological mapping, geochemical surveying, geophysical surveying, prospecting, trenching and drilling on the property, located in British Columbia, Canada in the prolific Quesnel Trough area.
The press release stated that various parts of the Properties have been explored by a number of companies in the 1980s and 1990s. Royal Canadian Ventures explored the ground from 1968 to 1971, and Guichon Explorco conducted geochemical and geophysical surveys from 1982-1983. In 1994 GWR Resources staked the ground and conducted geological mapping, soil sampling, a ground IP and magnetic survey, and a 12-hole 1,549 meter diamond drill program.
GGRI is focused on acquiring, developing and joint venturing with other junior or major gold mining companies with properties within North America.
Integrated wireless telecommunications company, HotCloud Mobile, Inc. (HOTM) announced on Thursday that the company is developing a cloud-based platform to host proprietary content that it “intends to push to smartphones, tablets and wireless devices purchased through HotCloudMobile.com and Stars Wireless, Inc.
“We previously announced that we are planning to aggressively pursue the creation of value-added apps designed for smartphones, and that the first step in this process was our partnership with Macrosolve,” said David J. Bleeden, CEO of HotCloud Mobile, Inc. in a June 30 press release. “The ‘App Cloud’ concept will allow us to monetize these apps by offering our customers a ‘channel’ from which they can customize and create the content that they want. It’s similar to a cable television network, where the customer chooses the channels they wish to subscribe to.”
HOTM is a supplier of wireless products and services designed to enhance the wireless experience. HotCloud offers the latest products on its website, including handsets, unlocked phones, specialty accessories, as well as phone insurance and exclusive mobile applications and licensed content from its in-house design team.
Penny stocks are loosely categorized companies with share prices of below $5 and with market caps of under $200 million. They are sometimes referred to as “the slot machines of the equity market” because of the risks involved. There may be a good place for penny stocks in the portfolio of an experienced, advanced investor, however, if you follow these steps.
Understand why penny stocks are considered a dangerous investment. Penny stocks are among the most volatile and most manipulated form of investment in the stock market. The companies usually have no track record of solid financial performance. In addition, the stocks are often manipulated by scam artists.
Get at least one year’s experience with mid- and large-cap stocks first. You should become adept at reading a balance sheet, income statement, and cash flow statement during this time.
Look for companies that have consistently generated cash and are growing their free cash flow over time.Avoid companies with a heavy debt load.
